BioCentury
ARTICLE | Clinical News

AVI preclinical data

March 26, 2001 8:00 AM UTC

AVII reported that in vitro, its c-myc and beta-hCG PMOs decreased cell viability of certain prostate cancer cell lines. Results were presented at the American Academy of Cancer Research meeting in Ne...